A popular blood pressure medication is under recall due to a possible metal contamination.
Breckenridge Pharmaceutical, Inc. issued a voluntary recall of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg.
The recall warns that using the affected product could cause “lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine.”
Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg
Breckenridge Pharmaceutical
It says the recalled lot shared intermediate material believed to be the source of metal contamination in a separate lot that was not released to the public.
As of November 16, Breckenridge had not received notice of any adverse events related to the recall.
The recalled lot was distributed across the U.S. to wholesalers and pharmacies between October 26 and November 4, 2026.
How to identify the recalled product:
Name: Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg
Package size: 100-count bottle
NDC: 51991-817-01
Lot number: PK25110035
Expiration date: May 2029
Anyone in possession of this product should stop taking it immediately and contact their physician or healthcare provider for medical advice and replacement instructions.
Return unused medication to the pharmacy it was obtained from.
If you have taken this product and experienced any related health problems, contact your doctor. You can also report adverse reactions from this product on the U.S. Food and Drug Administration’s website here.
Those with questions or concerns can contact Breckenridge’s designated recall service provider, Qualanaex, by phone at 1-855-736-0807 or by email at recall@qualanex.com.
